Article
Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report.
BMC pediatrics - 29 Aug 2018
Lundin Karin E, Wang Qing, Hamasy Abdulrahman, Marits Per, Uzunel Mehmet, Wirta Valtteri, Wikström Ann-Charlotte, Fasth Anders, Ekwall Olov, Smith C I Edvard
Abstract excerpt
BACKGROUND: A novel immunodeficiency, frequently accompanied by high serum-IgE, and caused by mutations in the PGM3 gene was described in 2014. To date there are no unique phenotype characteristics for PGM3 deficiency. PGM3 encodes a carbohydrate-modifying enzyme, phosphoglucomutase 3. Null-mutations are quite likely lethal, and to date only missense mutations or small deletions have been reported. Such mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
